Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Oct 8, 2020
Date Accepted: Jun 30, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Misalignment among Key Stakeholders in Digital Health: Mixed Methods Evaluation of Priorities for Patient-Facing Tools
ABSTRACT
Background:
There is widespread agreement on the promise of patient-facing digital health tools to transform healthcare. Yet there is a dramatic gap between promise and reality, with few tools in widespread use or with documented clinical effectiveness.
Objective:
To gain insight into the gap between the potential of patient-facing digital health tools and real-world outcomes.
Methods:
We interviewed and/or surveyed 22 experts across key stakeholder groups: venture capitalists, digital health companies, payers, and healthcare system providers/leaders – guided by a validated framework.
Results:
Our findings revealed that external policy/regulatory demands and internal organizational workflow and integration needs take priority over patient needs and preferences for digital health tools, driving lower patient acceptance rates. We discovered stakeholder misalignment: venture capitalists and companies focused more on external policy/regulatory demands, while payers and providers focused more on internal organizational workflow and integration needs.
Conclusions:
If stakeholders who pay for and develop technologies continue to be misaligned with those who implement them, it will be difficult to make achieve digital transformation.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.